Researchers Discover Key to Regenerating Blood Vessels

Summary: A new study reports researchers have identified a signaling pathway that appears to be vital in angiogenesis. The findings could help in the development of treatments to improve blood flow in ischemic tissue.

Source: SBP.

A new study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a signaling pathway that is essential for angiogenesis, the growth of new blood vessels from pre-existing vessels. The findings, published in Nature Communications, may improve current strategies to improve blood flow in ischemic tissue, such as that found in atherosclerosis and peripheral vascular disease associated with diabetes.

“Our research shows that the formation of fully functional blood vessels requires activation of protein kinase Akt by a protein called R-Ras, and this mechanism is necessary for the formation of the hallow structure, or lumen, of a blood vessel.” says Masanobu Komatsu, Ph.D., associate professor at SBP’s Lake Nona campus. “The findings are important because they shed new light on the biological process needed to increase blood flow in ischemic tissues.”

Previous efforts to treat ischemia by creating new blood vessels have focused on delivering angiogenic growth factors like vascular endothelial growth factor (VEGF) to ischemic sites. But all of these studies, including more than 25 phase II and III clinical trials, have failed to offer significant benefit to patients.

Image shows endothelial microtubules.
R-Ras stabilizes endothelial microtubules. Immunofluorescence of the total (green) and acetylated α-tubulin (d) or delta 2-tubulin (e) (magenta). NeuroscienceNews.com image is credited to Komatsu et al./Nature Communications.

Komatsu’s research team used a combination of 3D cell culture and living tissue to show that VEGF promotes vascularization, but the vessel structures formed are chaotic, unstable and non-functional. “Functional vessels need to have a lumen; a pipe-like opening that allows oxygenated blood and nutrients to travel through the body,” explains Komatsu, “and VEGF alone cannot fully support the formation of such a vessel structure.”

“Generating new blood vessels is similar to the way trees grow; sprouts develop from existing vessels and then branch out further and further to restore vascularity, says Fangfei Li, Ph.D., postdoctoral associate in Komatsu’s lab and lead author of the paper. “This study shows that there are distinct steps and signals that control the process.

“First, VEGF activates Akt to induce endothelial cells to sprout. Then, R-Ras activates Akt to induce lumen formation,” explains Li. “The second step involving Akt activation by R-Ras stabilizes the microtubule cytoskeleton in endothelial cells, creating a steady architecture that promotes lumen formation,” explains Li.

“We propose that VEGF and R-Ras activation of Akt signaling are complementary to each other, both are necessary to generate fully functional blood vessels to repair ischemic tissue,” says Komatsu. “Our next step is to work toward promoting the combined signaling of Akt in clinical studies; prompting R-Ras activation through either gene therapy or pharmacologically in parallel with VEGF therapy,” says Komatsu.

Junko Sawada, a staff scientist in the Komatsu lab, was a co-author of this study.

About this neuroscience research article

Funding: Funding sources for this research came, in part, from the National Cancer Institute (CA125255), the National Science Foundation Grant (CBET-1403535), the American Heart Association, the Bankhead-Coley Cancer Research Program (4BB17), and the Florida Breast Cancer Foundation.

Source: Susan Gammon – SBP
Publisher: Organized by NeuroscienceNews.com.
Image Source: NeuroscienceNews.com image is credited to Komatsu et al./Nature Communications.
Original Research: Full open access research for “R-Ras-Akt axis induces endothelial lumenogenesis and regulates the patency of regenerating vasculature” by Fangfei Li, Junko Sawada & Masanobu Komatsu in Nature Communications. Published online November 23 2017 doi:10.1038/s41467-017-01865-x

Cite This NeuroscienceNews.com Article

[cbtabs][cbtab title=”MLA”]SBP “Researchers Discover Key to Regenerating Blood Vessels.” NeuroscienceNews. NeuroscienceNews, 24 November 2017.
<https://neurosciencenews.com/blood-vessel-regeneration-8026/>.[/cbtab][cbtab title=”APA”]SBP (2017, November 24). Researchers Discover Key to Regenerating Blood Vessels. NeuroscienceNews. Retrieved November 24, 2017 from https://neurosciencenews.com/blood-vessel-regeneration-8026/[/cbtab][cbtab title=”Chicago”]SBP “Researchers Discover Key to Regenerating Blood Vessels.” https://neurosciencenews.com/blood-vessel-regeneration-8026/ (accessed November 24, 2017).[/cbtab][/cbtabs]


Abstract

R-Ras-Akt axis induces endothelial lumenogenesis and regulates the patency of regenerating vasculature

The formation of endothelial lumen is fundamental to angiogenesis and essential to the oxygenation of hypoxic tissues. The molecular mechanism underlying this important process remains obscure. Here, we show that Akt activation by a Ras homolog, R-Ras, stabilizes the microtubule cytoskeleton in endothelial cells leading to endothelial lumenogenesis. The activation of Akt by the potent angiogenic factor VEGF-A does not strongly stabilize microtubules or sufficiently promote lumen formation, hence demonstrating a distinct role for the R-Ras-Akt axis. We show in mice that this pathway is important for the lumenization of new capillaries and microvessels developing in ischemic muscles to allow sufficient tissue reperfusion after ischemic injury. Our work identifies a role for Akt in lumenogenesis and the significance of the R-Ras-Akt signaling for the patency of regenerating blood vessels.

“R-Ras-Akt axis induces endothelial lumenogenesis and regulates the patency of regenerating vasculature” by Fangfei Li, Junko Sawada & Masanobu Komatsu in Nature Communications. Published online November 23 2017 doi:10.1038/s41467-017-01865-x

Feel free to share this Neuroscience News.
Join our Newsletter
I agree to have my personal information transferred to AWeber for Neuroscience Newsletter ( more information )
Sign up to receive our recent neuroscience headlines and summaries sent to your email once a day, totally free.
We hate spam and only use your email to contact you about newsletters. You can cancel your subscription any time.